RFG Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Sell |
571
-186
| -25% | -$82.8K | 0.01% | 834 |
|
|
2025
Q1 | $367K | Buy |
757
+82
| +12% | +$39.8K | 0.01% | 663 |
|
|
2024
Q4 | $272K | Sell |
675
-1,001
| -60% | -$403K | 0.01% | 675 |
|
|
2024
Q3 | $779K | Buy |
1,676
+244
| +17% | +$113K | 0.02% | 409 |
|
|
2024
Q2 | $671K | Buy |
1,432
+17
| +1% | +$7.97K | 0.02% | 428 |
|
|
2024
Q1 | $591K | Buy |
1,415
+331
| +31% | +$138K | 0.02% | 473 |
|
|
2023
Q4 | $441K | Buy |
1,084
+227
| +26% | +$92.4K | 0.02% | 466 |
|
|
2023
Q3 | $298K | Buy |
857
+22
| +3% | +$7.65K | 0.01% | 513 |
|
|
2023
Q2 | $294K | Buy |
835
+71
| +9% | +$25K | 0.01% | 532 |
|
|
2023
Q1 | $241K | Buy |
+764
| New | +$241K | 0.01% | 562 |
|
|
2019
Q4 | – | Sell |
-1,740
| Closed | -$295K | – | 382 |
|
|
2019
Q3 | $295K | Buy |
1,740
+118
| +7% | +$20K | 0.06% | 250 |
|
|
2019
Q2 | $300K | Buy |
+1,622
| New | +$300K | 0.07% | 238 |
|